Amerant Bancorp (NASDAQ:AMTB – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.04, Zacks reports. The company had revenue of ($999.00) million for the quarter, compared to the consensus estimate of $99.39 million. Amerant Bancorp had a net margin of 3.15% and a return on equity of 7.78%. During the same period in the previous year, the firm earned $0.64 EPS.
Amerant Bancorp Price Performance
NASDAQ AMTB traded up $0.22 on Friday, reaching $20.88. 225,920 shares of the company’s stock traded hands, compared to its average volume of 125,890. Amerant Bancorp has a 12 month low of $17.39 and a 12 month high of $27.00. The company has a debt-to-equity ratio of 1.25, a current ratio of 0.97 and a quick ratio of 0.89. The stock has a 50-day simple moving average of $20.99 and a 200 day simple moving average of $21.79. The stock has a market cap of $698.02 million, a PE ratio of 33.74 and a beta of 0.99.
Amerant Bancorp Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Shareholders of record on Thursday, November 14th will be given a dividend of $0.09 per share. This represents a $0.36 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date is Thursday, November 14th. Amerant Bancorp’s payout ratio is currently 59.02%.
Wall Street Analysts Forecast Growth
Get Our Latest Report on Amerant Bancorp
About Amerant Bancorp
Amerant Bancorp Inc operates as the bank holding company for Amerant Bank, N.A. that provides banking products and services to individuals and businesses in the United States and internationally. It offers checking, savings, business, and money market accounts; cash management services; and certificates of deposits.
See Also
- Five stocks we like better than Amerant Bancorp
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Texas Roadhouse Stock Steering for New Highs This Year
- Investing In Preferred Stock vs. Common Stock
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What is a support level?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Amerant Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amerant Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.